Press release
Chagas Disease Market Growth, Trends & Forecast 2025 | Top Key players - Bayer AG, Novartis AG, Laboratorio Elea Phoenix.
Chagas Disease Market
The Global Chagas Disease Market reached US$ 268 million in 2023 and is expected to reach US$ 467 million by 2031, growing with a CAGR of 7.2% during the forecast period 2024-2031.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/chagas-disease-market?sz
The Chagas Disease Market revolves around the development, production, and sale of diagnostic tools, treatments, and preventive solutions for Chagas disease-a tropical parasitic illness caused by the Trypanosoma cruzi parasite. This market includes drugs, diagnostic kits, and vector control methods aimed at managing and reducing the impact of this life-threatening disease, primarily affecting Latin America but increasingly recognized worldwide.
Major players in the Chagas Disease Market
The prominent players in Chagas Disease market research report are: Bayer AG, Novartis AG, Laboratorio Elea Phoenix, Maprimed, Nortec Quimica SA, Upsher-Smith Laboratories, Inc., Merck and Co., ChemFish Tokyo Co., Ltd., Anant Pharmaceuticals Pvt. Ltd., and InBios International Inc.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
In February 2024, Brazil launched the Healthy Brazil program in collaboration with the World Health Organization (WHO). This new public health initiative aims to tackle 14 diseases-like malaria, Chagas disease, HIV, and tuberculosis-that disproportionately affect vulnerable communities. The goal is to either eliminate these illnesses as major public health problems or significantly reduce their impact on at-risk populations.
In January 2024, a clinical trial led by DNDi in Spain, involving mainly Latin American participants, tested the drug fexinidazole for treating Chagas disease. The results showed that while the drug was generally well tolerated at low doses, it unfortunately did not succeed in fully eliminating the parasite Trypanosoma cruzi, which causes the disease.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/chagas-disease-market
Market Segments
By Type: Acute Chagas Disease, Chronic Chagas Disease.
By Drugs: Benznidazole , Nifurtimox, Others.
By Route of administration: Oral , Parenteral.
By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.
The Chagas Disease industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Chagas Disease Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chagas Disease Market Growth, Trends & Forecast 2025 | Top Key players - Bayer AG, Novartis AG, Laboratorio Elea Phoenix. here
News-ID: 4019380 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Pemphigus Vulgaris Treatment Market Set for Rapid Growth Amid Risi …
Market Size and Growth:
The Global Pemphigus Vulgaris Treatment Market size reached US$ 473.4 million in 2023 and is expected to reach US$ 896.1 million by 2031 growing with a CAGR of 8.3% during the forecast period 2024-2031.
The Pemphigus Vulgaris Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
United States Compartment Syndrome Treatment Market Set to Surge with Innovative …
Market Size and Growth:
The Global Compartment Syndrome Treatment Market size reached US$ 316.8 million in 2023 and is expected to reach US$ 516.6 million by 2031 growing with a CAGR of 6.3% during the forecast period 2024-2031.
The Compartment Syndrome Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
United States VR and AR Technology for Healthcare Market Set for Explosive Growt …
Market Size and Growth:
The Global VR/AR Technology for Healthcare Market size reached US$ 3.75 billion in 2023 and is expected to reach US$ 12.14 billion by 2031 growing with a CAGR of 15.8% during the forecast period 2024-2031.
The VR and AR Technology for Healthcare Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM…
United States Hydrogen Bus Market Accelerates Toward a Sustainable Future with R …
Market Size and Growth:
The Hydrogen Bus Market size reached US$ 1.68 billion in 2024 and is expected to reach US$ 13.21 billion by 2032, growing with a CAGR of 29.4% during the forecast period 2025-2032.
The Hydrogen Bus Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
More Releases for Chagas
Chagas Disease Market Emerging Trends and Growth Prospects 2034
Introduction
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening parasitic illness caused by Trypanosoma cruzi. It is transmitted primarily through triatomine bugs (kissing bugs), blood transfusions, congenital infections, or contaminated food. Once considered confined to Latin America, globalization, migration, and increased travel have made Chagas disease a global public health concern.
While millions are infected worldwide, the disease remains classified as a neglected tropical disease (NTD), with limited treatment…
Chagas Disease Treatment Market: An In-Depth Analysis
The global Chagas Disease Treatment Market was valued at approximately USD 450 million in 2024 and is projected to reach around USD 700 million by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033 .
Chagas Disease Treatment Market Overview
Chagas disease, caused by the Trypanosoma cruzi parasite, remains a significant public health challenge, particularly in Latin America. The market's growth is driven by increasing awareness,…
Chagas Disease Drug Market Size, Share, Growth Forecast 2023-2032
Chagas disease, caused by the parasite Trypanosoma cruzi, remains a significant public health concern, particularly in Latin America. With an estimated 6 to 7 million people worldwide affected by this neglected tropical disease, the demand for effective treatments has spurred the growth of the Chagas Disease Drug Market. As of 2022, the market size stood at a commendable USD 265.2 million, and projections indicate a robust expansion, with expectations to…
2018 – 2024 Chagas Disease Management Market | Global Industry Report
2018 – 2024 Chagas Disease Management Market | Global Industry Report
A Recent Market Study On Chagas Disease And Its Current Trends And Future Insights
Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen…
Chagas Disease Treatment Market Global Industry Insights, and Forecast till 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,…
Chagas Disease Treatment Market - Global Industry Insights, and Forecast till 20 …
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,…
